Rapid Normalization of Portopulmonary Hypertension After Living Donor Liver Transplantation

Transplantation Proceedings

Volumn 41, Issue 5, 2009, Pages 1976-1978

  Sugimachi, K ^a   Soejima, Y ^a   Morita, K ^a   Ueda, S ^a   Fukuhara, T ^a   Nagata, S ^a   Ikegami, T ^a   Taketomi, A ^a   Maehara, Y ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; HYPERTENSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROSTACYCLIN; TACROLIMUS;

ADULT; ARTICLE; ASCITES; BLOOD PRESSURE MONITORING; CASE REPORT; CONTINUOUS INFUSION; DRUG DOSE INCREASE; ECHOGRAPHY; ESOPHAGUS VARICES; HEART CATHETERIZATION; HEPATITIS C; HUMAN; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; LUNG ARTERY PRESSURE; MALE; PORTAL HYPERTENSION; PORTOPULMONARY HYPERTENSION; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME;

ANTIHYPERTENSIVE AGENTS; EPOPROSTENOL; HEMODYNAMICS; HEPATITIS C, CHRONIC; HUMANS; HYPERTENSION, PORTAL; HYPERTENSION, PULMONARY; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 67249144802     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.02.095     Document Type: Article

References (22)

1. Hoeper M.M., Krowka M.J., and Strassburg C.P. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet 363 (2004) 1461
2. Krowka M.J., Plevak D.J., Findlay J.Y., et al. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl 6 (2000) 443
3. Uchiyama H., Soejima Y., Taketomi A., et al. Successful adult-to-adult living donor liver transplantation in a patient with moderate to severe portopulmonary hypertension. Liver Transpl 12 (2006) 481
4. Tan H.P., Markowitz J.S., Montgomery R.A., et al. Liver transplantation in patients with severe portopulmonary hypertension treated with preoperative chronic intravenous epoprostenol. Liver Transpl 7 (2001) 745
5. Plotkin J.S., Kuo P.C., Rubin L.J., et al. Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension. Transplantation 65 (1998) 457
6. Minder S., Fischler M., Muellhaupt B., et al. Intravenous iloprost bridging to orthotopic liver transplantation in portopulmonary hypertension. Eur Respir J 24 (2004) 703
7. Levy M.T., Torzillo P., Bookallil M., et al. Case report: delayed resolution of severe pulmonary hypertension after isolated liver transplantation in a patient with cirrhosis. J Gastroenterol Hepatol 11 (1996) 734
8. Mandell M.S. Critical care issues: portopulmonary hypertension. Liver Transpl 6 4 suppl 1 (2000) S36
9. Fix O.K., Bass N.M., De Marco T., et al. Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol. Liver Transpl 13 (2007) 875
10. Barst R.J., Rubin L.J., Long W.A., et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. N Engl J Med 334 (1996) 296
11. Kuo P.C., Johnson L.B., Plotkin J.S., et al. Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension. Transplantation 63 (1997) 604
12. Krowka M.J., Frantz R.P., McGoon M.D., et al. Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): a study of 15 patients with moderate to severe portopulmonary hypertension. Hepatology 30 (1999) 641
13. Kett D.H., Acosta R.C., Campos M.A., et al. Recurrent portopulmonary hypertension after liver transplantation: management with epoprostenol and resolution after retransplantation. Liver Transpl 7 (2001) 645
14. Sugimoto H., Hirota M., Kure S., et al. Normal hepatic hemodynamics during early postoperative period in recipients with adult live donor liver transplantation. Transplant Proc 39 (2007) 160
15. Ramsay M.A., Simpson B.R., Nguyen A.T., et al. Severe pulmonary hypertension in liver transplant candidates. Liver Transpl Surg 3 (1997) 494
16. Prager M.C., Cauldwell C.A., Ascher N.L., et al. Pulmonary hypertension associated with liver disease is not reversible after liver transplantation. Anesthesiology 77 (1992) 375
17. Rafanan A.L., Maurer J., Mehta A.C., et al. Progressive portopulmonary hypertension after liver transplantation treated with epoprostenol. Chest 118 (2000) 1497
18. Koneru B., Fisher A., Wilson D.J., et al. De novo diagnosis of portopulmonary hypertension following liver transplantation. Am J Transplant 2 (2002) 883
19. Sussman N., Kaza V., Barshes N., et al. Successful liver transplantation following medical management of portopulmonary hypertension: a single-center series. Am J Transplant 6 (2006) 2177
20. Soejima Y., Taketomi A., Yoshizumi T., et al. Feasibility of left lobe living donor liver transplantation between adults: an 8-year, single-center experience of 107 cases. Am J Transplant 6 5 Pt 1 (2006) 1004
21. Ramsay M.A., Spikes C., East C.A., et al. The perioperative management of portopulmonary hypertension with nitric oxide and epoprostenol. Anesthesiology 90 (1999) 299
22. Laving A., Khanna A., Rubin L., et al. Successful liver transplantation in a child with severe portopulmonary hypertension treated with epoprostenol. J Pediatr Gastroenterol Nutr 41 (2005) 466